Almac

Assessing the strategic impact of supply chain management

Thursday, June 15, 2017

The globalization of clinical trials and more complex protocols, which include adaptive designs and those for targeted therapies, have driven the need for new practices and strategies to reduce waste and inefficiencies in the clinical supply logistics area.

[Read More]

RCSI, Almac partner on target therapy-resistant cancer tumors

Wednesday, February 15, 2017

RCSI (Royal College of Surgeons in Ireland) and Almac Discovery, a biopharmaceutical company focused on discovering and identifying innovative therapeutics for the treatment of cancer, have announced a major research collaboration that aims to gain a new understanding of how to target tumor cells that are resistant to cancer therapies and cause cancer to spread to other parts of the body. The project will explore the potential of a drug, based on initial research by RCSI’s Professor Tracy Robson and developed by Almac Discovery, which is currently undergoing a phase I dose escalation trial for patients with solid tumors. It is expected that the trial will be expanded in a biomarker selected patient population within ovarian cancer, however the drug, ALM201, has the potential to treat a range of other cancers.

[Read More]

Almac Group launches temperature management software

Monday, January 30, 2017

Almac Group, the global contract pharmaceutical development and manufacturing organization, has launched TempEZ—a temperature management software—and the inaugural offering from Almac’s “Next Generation Temperature Management Portfolio.” TempEZ is a web-based platform providing clients with a single database to store temperature data and to ensure regulatory compliance, thereby safeguarding the quality and integrity of drug product.

[Read More]

Almac Group, inVentiv Health partner

Thursday, December 8, 2016

Almac Clinical Technologies, part of the Almac Group, a privately held contract pharmaceutical development and manufacturing organization, has announced the formation of a strategic partnership with inVentiv Health, a biopharma outsourcing company combining a leading CRO and the industry’s only contract commercial organization (CCO). The partnership presents an opportunity for both organizations to provide clients and sites with streamlined access to best-in-class clinical trial Interactive Response Technology (IRT) solutions.

[Read More]

Almac Group adds 312 jobs

Tuesday, November 15, 2016

Almac Group, a global contract pharmaceutical development and manufacturing organization, announced plans to expand its operations in Europe and North America, increasing its global headcount to reach 5,000 by 2017.

[Read More]

Almac opens companion diagnostic laboratory in North Carolina

Thursday, March 10, 2016

Almac Group’s Diagnostics Business Unit has opened a new companion diagnostic development facility located in the Research Triangle Park region of North Carolina. The North Carolina facility will provide a U.S. base to support Almac’s increased demand for its CDx development partnerships as well as a CLIA-accredited laboratory to support the downstream delivery of assays for patient testing.

[Read More]